Letter: should we have to include baclofen in the GORD therapy armamentarium? authors' reply

被引：1
作者：
Raymenants, Karlien [1 ,2 ]
Vandenbergh, Jolinde [1 ]
Tack, Jan [1 ,2 ]
机构：
[1] Univ Leuven, Univ Hosp Gasthuisberg, Dept Chron Dis & Metab ChroMeta, Translat Res Ctr Gastrointestinal Dis TARGID, O&N I Bus 701,Herestr 49, B-3000 Leuven, Belgium
[2] Univ Hosp Leuven UZ Leuven, Dept Gastroenterol, Leuven, Belgium
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2022年 / 56卷 / 08期
关键词：
SYMPTOMS;
D O I：
10.1111/apt.17214
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1308 / 1309
页数：2
相关论文
共 10 条
[1]   Esophageal Disorders [J].
Aziz, Qasim ;
Fass, Ronnie ;
Gyawali, C. Prakash ;
Miwa, Hiroto ;
Pandolfino, John E. ;
Zerbib, Frank .
GASTROENTEROLOGY, 2016, 150 (06) :1368-1379
[2]   Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease [J].
Ciccaglione, AF ;
Marzio, L .
GUT, 2003, 52 (04) :464-470
[3]   Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn [J].
Frazzoni, Marzio ;
Frazzoni, Leonardo ;
Ribolsi, Mentore ;
De Bortoli, Nicola ;
Tolone, Salvatore ;
Russo, Salvatore ;
Conigliaro, Rita ;
Penagini, Roberto ;
Fuccio, Lorenzo ;
Zagari, Rocco Maurizio ;
Savarino, Edoardo .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) :1423-1430
[4]   Clinical trial: a controlled trial of baclofen add-on therapy in PPI-refractory gastro-oesophageal reflux symptoms [J].
Pauwels, Ans ;
Raymenants, Karlien ;
Geeraerts, Annelies ;
Boecxstaens, Veerle ;
Masuy, Imke ;
Broers, Charlotte ;
Vanuytsel, Tim ;
Tack, Jan .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) :231-239
[5]   Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring [J].
Rengarajan, Arvind ;
Savarino, Edoardo ;
Della Coletta, Marco ;
Ghisa, Matteo ;
Patel, Amit ;
Gyawali, C. Prakash .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) :589-595
[6]   Letter: should we have to include baclofen in the GORD therapy armamentarium? [J].
Ribolsi, Mentore ;
Savarino, Edoardo .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) :1306-1307
[7]   Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms [J].
Ribolsi, Mentore ;
Frazzoni, Marzio ;
Cicala, Michele ;
Savarino, Edoardo .
NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (01)
[8]   Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus [J].
Ribolsi, Mentore ;
Frazzoni, Marzio ;
Marabotto, Elisa ;
De Carlo, Giovanni ;
Ziola, Sebastiano ;
Maniero, Daria ;
Balestrieri, Paola ;
Cicala, Michele ;
Savarino, Edoardo .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) :412-418
[9]   Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH [J].
Vela, MF ;
Tutuian, R ;
Katz, PO ;
Castell, DO .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (02) :243-251
[10]   Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors [J].
Zerbib, F. ;
Duriez, A. ;
Roman, S. ;
Capdepont, M. ;
Mion, F. .
GUT, 2008, 57 (02) :156-160
1